Instanosis, Inc.

Publicly observed

Milford, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

Item	Value	Source	Status
Country	US	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
City / locality	Milford	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
Name	Instanosis, Inc.	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
UEI (U.S. federal entity ID)	CA5GQKREPCE4	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed

Grant15 Jun 2025Publicly observed
NIH SBIR/STTR award: A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test
USD 1,414,924.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Grant15 Jun 2025Publicly observed
NIH SBIR/STTR award: A Rapid, Sensitive and Instrument-free Oral Fluid Fentanyl Test
USD 1,576,513.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Grant1 May 2024Publicly observed
NIH SBIR/STTR award: Addressing Emerging Drug Threats with InstaStrip Rapid Tests
USD 760,678.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Grant1 May 2024Publicly observed
NIH SBIR/STTR award: Addressing Emerging Drug Threats with InstaStrip Rapid Tests
USD 954,553.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Grant1 Apr 2024Publicly observed
NIH SBIR/STTR award: Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing
USD 1,399,878.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Grant1 Apr 2024Publicly observed
NIH SBIR/STTR award: Rapid, Instrument-free and High Sensitivity Over-the-counter Urine Fentanyl Testing
USD 1,544,462.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.